Drug pipeline
Explore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Solute carrier family 30 member 8 (SLC30A8), commonly known as zinc transporter 8 (ZnT8), is a proton-coupled zinc antiporter predominantly expressed in the secretory granules of pancreatic beta cells. It plays a critical role in glucose homeostasis by transporting cytosolic zinc into insulin secretory granules, where zinc ions are essential for the crystallization, stabilization, and storage of insulin. Genetic studies have highlighted SLC30A8 as a major locus in diabetes; common variants like the rs13266634 polymorphism increase susceptibility to type 2 diabetes (T2D), whereas rare loss-of-function (LoF) mutations confer significant protection against T2D by enhancing glucose-stimulated insulin secretion. Additionally, ZnT8 is a major autoantigen in type 1 diabetes (T1D), with autoantibodies against it serving as key diagnostic biomarkers. Therapeutic strategies targeting SLC30A8 include the development of small-molecule inhibitors or RNAi therapeutics to mimic the protective LoF phenotype for T2D, as well as monoclonal antibodies (such as mAb43 and Isle43) designed to mask the extracellular epitopes of ZnT8, thereby shielding beta cells from autoimmune destruction in T1D.
Antigenic masking of cell-surface ZnT8 to prevent autoimmune recognition; Inhibition of zinc transport activity to enhance insulin secretion
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Solute carrier family 30 member 8 (SLC30A8).